Bio-Rad Laboratories, Inc., a leader in life science research and clinical diagnostics products, today announced that ...

Bio-Rad Laboratories, Inc. BIO is well-poised to grow in the upcoming quarters, courtesy of its strong traction in the QX600 Droplet Digital PCR (ddPCR) platform. Demand for its quality control and ...

(1) Excluded items identified in the reconciliation schedule are tax effected by application of a non-GAAP effective tax rate. The non-GAAP tax provision is adjusted for items, the nature of which and ...

On May 18, 2026, Elliott Investment Management disclosed a significant stake in Bio-Rad Laboratories and began pressing for changes to improve shareholder outcomes, focusing in part on the company’s ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jefferies Global Healthcare Conference 2026 June 3, 2026 8:45 AM EDTCompany ParticipantsRoop Lakkaraju - Executive VP ...

Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories, Inc. BIO and is expected ...

View Bio-Rad Laboratories, Inc. Class B BIO.B stock quote prices, financial information, real-time forecasts, and company news from CNN.

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an ...

Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24 ...